nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RBP1—oviduct—uterine cancer	0.0268	0.124	CbGeAlD
Acitretin—CYP26A1—decidua—uterine cancer	0.0106	0.0494	CbGeAlD
Acitretin—CYP26A1—endometrium—uterine cancer	0.0101	0.0469	CbGeAlD
Acitretin—CYP26A1—female reproductive system—uterine cancer	0.00836	0.0388	CbGeAlD
Acitretin—RBP1—epithelium—uterine cancer	0.00672	0.0312	CbGeAlD
Acitretin—RBP1—uterine cervix—uterine cancer	0.00666	0.031	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—uterine cancer	0.00647	0.0301	CbGeAlD
Acitretin—RXRA—renal system—uterine cancer	0.00642	0.0298	CbGeAlD
Acitretin—RBP1—decidua—uterine cancer	0.00635	0.0295	CbGeAlD
Acitretin—RBP1—renal system—uterine cancer	0.00623	0.029	CbGeAlD
Acitretin—RARA—myometrium—uterine cancer	0.00607	0.0282	CbGeAlD
Acitretin—RBP1—uterus—uterine cancer	0.00555	0.0258	CbGeAlD
Acitretin—RXRB—decidua—uterine cancer	0.0054	0.0251	CbGeAlD
Acitretin—RXRA—female reproductive system—uterine cancer	0.00514	0.0239	CbGeAlD
Acitretin—RBP1—female reproductive system—uterine cancer	0.00499	0.0232	CbGeAlD
Acitretin—RARG—decidua—uterine cancer	0.00479	0.0223	CbGeAlD
Acitretin—RXRA—female gonad—uterine cancer	0.00468	0.0217	CbGeAlD
Acitretin—RARB—female reproductive system—uterine cancer	0.00462	0.0215	CbGeAlD
Acitretin—RBP1—female gonad—uterine cancer	0.00454	0.0211	CbGeAlD
Acitretin—RBP1—vagina—uterine cancer	0.00451	0.021	CbGeAlD
Acitretin—RARA—decidua—uterine cancer	0.0045	0.0209	CbGeAlD
Acitretin—RARA—renal system—uterine cancer	0.00442	0.0205	CbGeAlD
Acitretin—RARG—mammalian vulva—uterine cancer	0.0044	0.0204	CbGeAlD
Acitretin—RARA—endometrium—uterine cancer	0.00428	0.0199	CbGeAlD
Acitretin—RARB—female gonad—uterine cancer	0.0042	0.0195	CbGeAlD
Acitretin—RARG—uterus—uterine cancer	0.00419	0.0195	CbGeAlD
Acitretin—RARB—vagina—uterine cancer	0.00418	0.0194	CbGeAlD
Acitretin—RARA—uterus—uterine cancer	0.00394	0.0183	CbGeAlD
Acitretin—RXRB—female gonad—uterine cancer	0.00386	0.0179	CbGeAlD
Acitretin—RXRB—vagina—uterine cancer	0.00384	0.0178	CbGeAlD
Acitretin—RARG—female reproductive system—uterine cancer	0.00377	0.0175	CbGeAlD
Acitretin—RARA—female reproductive system—uterine cancer	0.00354	0.0165	CbGeAlD
Acitretin—RARG—female gonad—uterine cancer	0.00343	0.0159	CbGeAlD
Acitretin—RARG—vagina—uterine cancer	0.00341	0.0158	CbGeAlD
Acitretin—RARA—female gonad—uterine cancer	0.00322	0.015	CbGeAlD
Acitretin—RBP1—lymph node—uterine cancer	0.00292	0.0136	CbGeAlD
Acitretin—RARB—lymph node—uterine cancer	0.0027	0.0126	CbGeAlD
Acitretin—RARG—lymph node—uterine cancer	0.0022	0.0102	CbGeAlD
Acitretin—RARA—lymph node—uterine cancer	0.00207	0.00963	CbGeAlD
Acitretin—ALB—lymph node—uterine cancer	0.00117	0.00543	CbGeAlD
Acitretin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000405	0.000845	CcSEcCtD
Acitretin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000404	0.000841	CcSEcCtD
Acitretin—Alopecia—Etoposide—uterine cancer	0.000401	0.000835	CcSEcCtD
Acitretin—Vomiting—Progesterone—uterine cancer	0.0004	0.000834	CcSEcCtD
Acitretin—Rash—Progesterone—uterine cancer	0.000397	0.000827	CcSEcCtD
Acitretin—Dermatitis—Progesterone—uterine cancer	0.000397	0.000826	CcSEcCtD
Acitretin—Headache—Progesterone—uterine cancer	0.000394	0.000822	CcSEcCtD
Acitretin—Hot flush—Epirubicin—uterine cancer	0.000393	0.000818	CcSEcCtD
Acitretin—Increased appetite—Epirubicin—uterine cancer	0.000391	0.000815	CcSEcCtD
Acitretin—Diabetes mellitus—Doxorubicin—uterine cancer	0.000391	0.000814	CcSEcCtD
Acitretin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.000813	CcSEcCtD
Acitretin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000389	0.000811	CcSEcCtD
Acitretin—Menopausal symptoms—Epirubicin—uterine cancer	0.000389	0.000811	CcSEcCtD
Acitretin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000389	0.00081	CcSEcCtD
Acitretin—Photosensitivity—Doxorubicin—uterine cancer	0.000387	0.000806	CcSEcCtD
Acitretin—Decreased appetite—Dactinomycin—uterine cancer	0.000387	0.000806	CcSEcCtD
Acitretin—Dysgeusia—Etoposide—uterine cancer	0.000387	0.000805	CcSEcCtD
Acitretin—Dermatitis bullous—Epirubicin—uterine cancer	0.000384	0.000801	CcSEcCtD
Acitretin—Fatigue—Dactinomycin—uterine cancer	0.000384	0.000799	CcSEcCtD
Acitretin—Back pain—Etoposide—uterine cancer	0.000382	0.000795	CcSEcCtD
Acitretin—Purpura—Epirubicin—uterine cancer	0.000381	0.000794	CcSEcCtD
Acitretin—Pain—Dactinomycin—uterine cancer	0.000381	0.000793	CcSEcCtD
Acitretin—Vascular purpura—Doxorubicin—uterine cancer	0.00038	0.000792	CcSEcCtD
Acitretin—Muscle spasms—Etoposide—uterine cancer	0.000379	0.000791	CcSEcCtD
Acitretin—Eczema—Doxorubicin—uterine cancer	0.000378	0.000788	CcSEcCtD
Acitretin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000377	0.000786	CcSEcCtD
Acitretin—Eye pain—Doxorubicin—uterine cancer	0.000377	0.000784	CcSEcCtD
Acitretin—Cerebrovascular accident—Epirubicin—uterine cancer	0.000375	0.000781	CcSEcCtD
Acitretin—Nausea—Progesterone—uterine cancer	0.000374	0.000779	CcSEcCtD
Acitretin—Diplopia—Epirubicin—uterine cancer	0.000367	0.000765	CcSEcCtD
Acitretin—Osteoarthritis—Epirubicin—uterine cancer	0.000367	0.000765	CcSEcCtD
Acitretin—Feeling abnormal—Dactinomycin—uterine cancer	0.000367	0.000764	CcSEcCtD
Acitretin—Ill-defined disorder—Etoposide—uterine cancer	0.000366	0.000763	CcSEcCtD
Acitretin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000364	0.000758	CcSEcCtD
Acitretin—Hot flush—Doxorubicin—uterine cancer	0.000363	0.000757	CcSEcCtD
Acitretin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.000756	CcSEcCtD
Acitretin—Increased appetite—Doxorubicin—uterine cancer	0.000362	0.000754	CcSEcCtD
Acitretin—Migraine—Epirubicin—uterine cancer	0.000362	0.000753	CcSEcCtD
Acitretin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00036	0.00075	CcSEcCtD
Acitretin—Menopausal symptoms—Doxorubicin—uterine cancer	0.00036	0.00075	CcSEcCtD
Acitretin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00036	0.000749	CcSEcCtD
Acitretin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000359	0.000749	CcSEcCtD
Acitretin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.000745	CcSEcCtD
Acitretin—Malaise—Etoposide—uterine cancer	0.000356	0.000741	CcSEcCtD
Acitretin—Dermatitis bullous—Doxorubicin—uterine cancer	0.000356	0.000741	CcSEcCtD
Acitretin—Purpura—Doxorubicin—uterine cancer	0.000353	0.000735	CcSEcCtD
Acitretin—Body temperature increased—Dactinomycin—uterine cancer	0.000352	0.000733	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—uterine cancer	0.000352	0.000733	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000347	0.000723	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000346	0.00114	CbGpPWpGaD
Acitretin—Cough—Etoposide—uterine cancer	0.000344	0.000717	CcSEcCtD
Acitretin—Blood creatinine increased—Epirubicin—uterine cancer	0.000344	0.000717	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000343	0.00113	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000342	0.00112	CbGpPWpGaD
Acitretin—Diplopia—Doxorubicin—uterine cancer	0.00034	0.000708	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—uterine cancer	0.00034	0.000708	CcSEcCtD
Acitretin—Liver function test abnormal—Epirubicin—uterine cancer	0.000339	0.000707	CcSEcCtD
Acitretin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.000706	CcSEcCtD
Acitretin—Dry skin—Epirubicin—uterine cancer	0.000337	0.000702	CcSEcCtD
Acitretin—Chest pain—Etoposide—uterine cancer	0.000336	0.0007	CcSEcCtD
Acitretin—Migraine—Doxorubicin—uterine cancer	0.000335	0.000697	CcSEcCtD
Acitretin—Discomfort—Etoposide—uterine cancer	0.000332	0.000692	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—INHBA—uterine cancer	0.000331	0.00109	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00033	0.00108	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00033	0.00108	CbGpPWpGaD
Acitretin—Hypersensitivity—Dactinomycin—uterine cancer	0.000328	0.000683	CcSEcCtD
Acitretin—RBP1—Disease—AKR1C3—uterine cancer	0.000328	0.00108	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000328	0.00107	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.000326	0.00107	CbGpPWpGaD
Acitretin—Gastritis—Epirubicin—uterine cancer	0.000325	0.000677	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000324	0.000675	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—uterine cancer	0.000324	0.000675	CcSEcCtD
Acitretin—Infection—Etoposide—uterine cancer	0.00032	0.000667	CcSEcCtD
Acitretin—RBP1—Disease—HMGA1—uterine cancer	0.00032	0.00105	CbGpPWpGaD
Acitretin—Asthenia—Dactinomycin—uterine cancer	0.000319	0.000665	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000318	0.000663	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000316	0.00104	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000316	0.00104	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000316	0.00104	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000314	0.00103	CbGpPWpGaD
Acitretin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000314	0.000654	CcSEcCtD
Acitretin—Skin disorder—Etoposide—uterine cancer	0.000313	0.000652	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000312	0.00102	CbGpPWpGaD
Acitretin—Dry skin—Doxorubicin—uterine cancer	0.000312	0.000649	CcSEcCtD
Acitretin—Hyperhidrosis—Etoposide—uterine cancer	0.000311	0.000649	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—uterine cancer	0.000311	0.000649	CcSEcCtD
Acitretin—CYP26A1—Metabolism—POLD1—uterine cancer	0.000311	0.00102	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.00031	0.00102	CbGpPWpGaD
Acitretin—Anorexia—Etoposide—uterine cancer	0.000307	0.00064	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—uterine cancer	0.000305	0.000634	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000303	0.000995	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.000302	0.000991	CbGpPWpGaD
Acitretin—Pancytopenia—Epirubicin—uterine cancer	0.000302	0.000628	CcSEcCtD
Acitretin—RXRA—Developmental Biology—HNF1B—uterine cancer	0.000302	0.000989	CbGpPWpGaD
Acitretin—Gastritis—Doxorubicin—uterine cancer	0.000301	0.000627	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.0003	0.000625	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—uterine cancer	0.0003	0.000625	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000299	0.000981	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKR1C1—uterine cancer	0.000298	0.000979	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000298	0.000976	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000298	0.000976	CbGpPWpGaD
Acitretin—Dysuria—Epirubicin—uterine cancer	0.000297	0.000619	CcSEcCtD
Acitretin—RXRA—Gene Expression—PHF1—uterine cancer	0.000294	0.000963	CbGpPWpGaD
Acitretin—RBP1—Disease—FBXW7—uterine cancer	0.000292	0.000959	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000291	0.000956	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKR1C1—uterine cancer	0.000291	0.000954	CbGpPWpGaD
Acitretin—Photosensitivity reaction—Epirubicin—uterine cancer	0.00029	0.000604	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—uterine cancer	0.000289	0.000603	CcSEcCtD
Acitretin—Weight increased—Epirubicin—uterine cancer	0.000289	0.000602	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000289	0.000948	CbGpPWpGaD
Acitretin—Pancreatitis—Doxorubicin—uterine cancer	0.000288	0.0006	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—uterine cancer	0.000287	0.000598	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000287	0.000942	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000287	0.00094	CbGpPWpGaD
Acitretin—Somnolence—Etoposide—uterine cancer	0.000286	0.000597	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000283	0.00093	CbGpPWpGaD
Acitretin—Vomiting—Dactinomycin—uterine cancer	0.000283	0.00059	CcSEcCtD
Acitretin—Rash—Dactinomycin—uterine cancer	0.000281	0.000585	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—uterine cancer	0.00028	0.000583	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000279	0.000917	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000279	0.000916	CbGpPWpGaD
Acitretin—Pancytopenia—Doxorubicin—uterine cancer	0.000279	0.000581	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000278	0.000579	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000278	0.000912	CbGpPWpGaD
Acitretin—Fatigue—Etoposide—uterine cancer	0.000278	0.000579	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000278	0.000578	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—uterine cancer	0.000276	0.000575	CcSEcCtD
Acitretin—Jaundice—Epirubicin—uterine cancer	0.000276	0.000575	CcSEcCtD
Acitretin—Pain—Etoposide—uterine cancer	0.000275	0.000574	CcSEcCtD
Acitretin—Constipation—Etoposide—uterine cancer	0.000275	0.000574	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—uterine cancer	0.000275	0.000573	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—uterine cancer	0.000275	0.000573	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—uterine cancer	0.000275	0.000572	CcSEcCtD
Acitretin—RXRB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000272	0.000891	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000272	0.000891	CbGpPWpGaD
Acitretin—Haematuria—Epirubicin—uterine cancer	0.00027	0.000562	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000269	0.000881	CbGpPWpGaD
Acitretin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000268	0.000559	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—uterine cancer	0.000267	0.000557	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—uterine cancer	0.000267	0.000556	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.000267	0.000875	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000266	0.000874	CbGpPWpGaD
Acitretin—Weight decreased—Doxorubicin—uterine cancer	0.000266	0.000554	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—uterine cancer	0.000266	0.000553	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—uterine cancer	0.000265	0.000553	CcSEcCtD
Acitretin—Nausea—Dactinomycin—uterine cancer	0.000264	0.000551	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—uterine cancer	0.000263	0.000549	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000263	0.000864	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—RRM2—uterine cancer	0.000259	0.00085	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—ESR1—uterine cancer	0.000258	0.000846	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000257	0.000535	CcSEcCtD
Acitretin—Urticaria—Etoposide—uterine cancer	0.000256	0.000533	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—uterine cancer	0.000255	0.000532	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—uterine cancer	0.000255	0.000532	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—uterine cancer	0.000255	0.000532	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—uterine cancer	0.000255	0.000531	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—uterine cancer	0.000255	0.00053	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—uterine cancer	0.000255	0.00053	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—uterine cancer	0.000255	0.00053	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—uterine cancer	0.000255	0.00053	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—uterine cancer	0.000254	0.000529	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—uterine cancer	0.000254	0.000529	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—uterine cancer	0.000253	0.000527	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000252	0.000828	CbGpPWpGaD
Acitretin—Pharyngitis—Epirubicin—uterine cancer	0.000252	0.000525	CcSEcCtD
Acitretin—CYP26A1—Metabolism—DCN—uterine cancer	0.000252	0.000826	CbGpPWpGaD
Acitretin—Oedema peripheral—Epirubicin—uterine cancer	0.00025	0.000522	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—uterine cancer	0.00025	0.00052	CcSEcCtD
Acitretin—RXRA—Gene Expression—CHD4—uterine cancer	0.00025	0.000819	CbGpPWpGaD
Acitretin—Epistaxis—Doxorubicin—uterine cancer	0.000247	0.000515	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—uterine cancer	0.000246	0.000512	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—uterine cancer	0.000245	0.00051	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000242	0.000796	CbGpPWpGaD
Acitretin—Eye disorder—Epirubicin—uterine cancer	0.000238	0.000495	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—uterine cancer	0.000237	0.000494	CcSEcCtD
Acitretin—CYP26A1—Metabolism—CYP11A1—uterine cancer	0.000237	0.000778	CbGpPWpGaD
Acitretin—Tinnitus—Epirubicin—uterine cancer	0.000237	0.000494	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—uterine cancer	0.000236	0.000492	CcSEcCtD
Acitretin—Flushing—Epirubicin—uterine cancer	0.000236	0.000491	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—ESR1—uterine cancer	0.000236	0.000774	CbGpPWpGaD
Acitretin—Rhinitis—Doxorubicin—uterine cancer	0.000236	0.000491	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—uterine cancer	0.000235	0.00049	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—uterine cancer	0.000235	0.00049	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000234	0.000487	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—uterine cancer	0.000233	0.000486	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000233	0.000763	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PGR—uterine cancer	0.000232	0.000763	CbGpPWpGaD
Acitretin—Oedema peripheral—Doxorubicin—uterine cancer	0.000232	0.000483	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—ESR1—uterine cancer	0.000231	0.000759	CbGpPWpGaD
Acitretin—Asthenia—Etoposide—uterine cancer	0.000231	0.000481	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—uterine cancer	0.000231	0.00048	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—AKR1C3—uterine cancer	0.00023	0.000753	CbGpPWpGaD
Acitretin—Immune system disorder—Epirubicin—uterine cancer	0.00023	0.000478	CcSEcCtD
Acitretin—RBP1—Disease—CDKN2B—uterine cancer	0.000229	0.000751	CbGpPWpGaD
Acitretin—Chills—Epirubicin—uterine cancer	0.000228	0.000475	CcSEcCtD
Acitretin—Pruritus—Etoposide—uterine cancer	0.000228	0.000475	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—uterine cancer	0.000227	0.000472	CcSEcCtD
Acitretin—Alopecia—Epirubicin—uterine cancer	0.000225	0.000468	CcSEcCtD
Acitretin—CYP26A1—Metabolism—AKR1C3—uterine cancer	0.000224	0.000735	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PGR—uterine cancer	0.000224	0.000734	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000224	0.000734	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000222	0.000728	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—ESR1—uterine cancer	0.000222	0.000727	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—ESR1—uterine cancer	0.000222	0.000727	CbGpPWpGaD
Acitretin—Erythema—Epirubicin—uterine cancer	0.000221	0.000461	CcSEcCtD
Acitretin—RARG—Gene Expression—EZH2—uterine cancer	0.000221	0.000724	CbGpPWpGaD
Acitretin—Diarrhoea—Etoposide—uterine cancer	0.00022	0.000459	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—uterine cancer	0.00022	0.000458	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—uterine cancer	0.000219	0.000457	CcSEcCtD
Acitretin—ALB—Folate Metabolism—CCL2—uterine cancer	0.000219	0.000717	CbGpPWpGaD
Acitretin—Flushing—Doxorubicin—uterine cancer	0.000218	0.000455	CcSEcCtD
Acitretin—Tension—Epirubicin—uterine cancer	0.000217	0.000452	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—uterine cancer	0.000217	0.000451	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—PGR—uterine cancer	0.000216	0.00071	CbGpPWpGaD
Acitretin—RXRA—PPARA activates gene expression—EP300—uterine cancer	0.000216	0.000708	CbGpPWpGaD
Acitretin—Nervousness—Epirubicin—uterine cancer	0.000215	0.000448	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000215	0.000704	CbGpPWpGaD
Acitretin—Back pain—Epirubicin—uterine cancer	0.000214	0.000446	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—YWHAE—uterine cancer	0.000213	0.0007	CbGpPWpGaD
Acitretin—Angiopathy—Doxorubicin—uterine cancer	0.000213	0.000444	CcSEcCtD
Acitretin—Dizziness—Etoposide—uterine cancer	0.000213	0.000444	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—uterine cancer	0.000213	0.000443	CcSEcCtD
Acitretin—RXRG—Gene Expression—PGR—uterine cancer	0.000213	0.000698	CbGpPWpGaD
Acitretin—Immune system disorder—Doxorubicin—uterine cancer	0.000212	0.000442	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000211	0.000693	CbGpPWpGaD
Acitretin—Chills—Doxorubicin—uterine cancer	0.000211	0.00044	CcSEcCtD
Acitretin—RXRA—Gene Expression—SUZ12—uterine cancer	0.000209	0.000686	CbGpPWpGaD
Acitretin—RBP1—Disease—SMAD3—uterine cancer	0.000209	0.000686	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PGR—uterine cancer	0.000209	0.000684	CbGpPWpGaD
Acitretin—Vision blurred—Epirubicin—uterine cancer	0.000209	0.000434	CcSEcCtD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000208	0.000684	CbGpPWpGaD
Acitretin—Alopecia—Doxorubicin—uterine cancer	0.000208	0.000433	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000206	0.000674	CbGpPWpGaD
Acitretin—Ill-defined disorder—Epirubicin—uterine cancer	0.000205	0.000428	CcSEcCtD
Acitretin—Vomiting—Etoposide—uterine cancer	0.000205	0.000427	CcSEcCtD
Acitretin—Erythema—Doxorubicin—uterine cancer	0.000205	0.000426	CcSEcCtD
Acitretin—RARG—Gene Expression—ESR2—uterine cancer	0.000205	0.000672	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FBXW7—uterine cancer	0.000205	0.000672	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NDUFB11—uterine cancer	0.000203	0.000668	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SRD5A2—uterine cancer	0.000203	0.000668	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CTNNB1—uterine cancer	0.000203	0.000667	CbGpPWpGaD
Acitretin—Rash—Etoposide—uterine cancer	0.000203	0.000423	CcSEcCtD
Acitretin—Dermatitis—Etoposide—uterine cancer	0.000203	0.000423	CcSEcCtD
Acitretin—RXRG—Gene Expression—EZH2—uterine cancer	0.000202	0.000663	CbGpPWpGaD
Acitretin—Headache—Etoposide—uterine cancer	0.000202	0.00042	CcSEcCtD
Acitretin—Tension—Doxorubicin—uterine cancer	0.000201	0.000418	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—uterine cancer	0.0002	0.000418	CcSEcCtD
Acitretin—RXRB—Gene Expression—PGR—uterine cancer	0.0002	0.000656	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PGR—uterine cancer	0.0002	0.000656	CbGpPWpGaD
Acitretin—Malaise—Epirubicin—uterine cancer	0.0002	0.000416	CcSEcCtD
Acitretin—RBP1—Disease—FGFR2—uterine cancer	0.000199	0.000654	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000199	0.000652	CbGpPWpGaD
Acitretin—Nervousness—Doxorubicin—uterine cancer	0.000199	0.000414	CcSEcCtD
Acitretin—RARB—Gene Expression—EZH2—uterine cancer	0.000198	0.00065	CbGpPWpGaD
Acitretin—Back pain—Doxorubicin—uterine cancer	0.000198	0.000413	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000198	0.000649	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000197	0.000647	CbGpPWpGaD
Acitretin—Muscle spasms—Doxorubicin—uterine cancer	0.000197	0.00041	CcSEcCtD
Acitretin—Cough—Epirubicin—uterine cancer	0.000193	0.000402	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—uterine cancer	0.000193	0.000402	CcSEcCtD
Acitretin—RBP1—Disease—MTHFR—uterine cancer	0.000192	0.00063	CbGpPWpGaD
Acitretin—Nausea—Etoposide—uterine cancer	0.000191	0.000399	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000191	0.000626	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR2—uterine cancer	0.000191	0.000625	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00019	0.000396	CcSEcCtD
Acitretin—RARA—Gene Expression—EZH2—uterine cancer	0.00019	0.000623	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—EZH2—uterine cancer	0.00019	0.000623	CbGpPWpGaD
Acitretin—Arthralgia—Epirubicin—uterine cancer	0.000188	0.000392	CcSEcCtD
Acitretin—Myalgia—Epirubicin—uterine cancer	0.000188	0.000392	CcSEcCtD
Acitretin—Chest pain—Epirubicin—uterine cancer	0.000188	0.000392	CcSEcCtD
Acitretin—Anxiety—Epirubicin—uterine cancer	0.000188	0.000391	CcSEcCtD
Acitretin—RXRG—Gene Expression—ESR2—uterine cancer	0.000187	0.000614	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000187	0.000612	CbGpPWpGaD
Acitretin—Discomfort—Epirubicin—uterine cancer	0.000186	0.000388	CcSEcCtD
Acitretin—Malaise—Doxorubicin—uterine cancer	0.000185	0.000385	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—uterine cancer	0.000184	0.000384	CcSEcCtD
Acitretin—RARB—Gene Expression—ESR2—uterine cancer	0.000184	0.000602	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—uterine cancer	0.000181	0.000376	CcSEcCtD
Acitretin—Infection—Epirubicin—uterine cancer	0.000179	0.000374	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—STK11—uterine cancer	0.000179	0.000587	CbGpPWpGaD
Acitretin—Cough—Doxorubicin—uterine cancer	0.000179	0.000372	CcSEcCtD
Acitretin—RARA—Gene Expression—ESR2—uterine cancer	0.000176	0.000577	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR2—uterine cancer	0.000176	0.000577	CbGpPWpGaD
Acitretin—Skin disorder—Epirubicin—uterine cancer	0.000175	0.000365	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—uterine cancer	0.000175	0.000364	CcSEcCtD
Acitretin—CYP26A1—Metabolism—CYP19A1—uterine cancer	0.000174	0.000572	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—STK11—uterine cancer	0.000174	0.000572	CbGpPWpGaD
Acitretin—Myalgia—Doxorubicin—uterine cancer	0.000174	0.000363	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—uterine cancer	0.000174	0.000363	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—uterine cancer	0.000174	0.000363	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—uterine cancer	0.000174	0.000362	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000174	0.00057	CbGpPWpGaD
Acitretin—Discomfort—Doxorubicin—uterine cancer	0.000172	0.000359	CcSEcCtD
Acitretin—Anorexia—Epirubicin—uterine cancer	0.000172	0.000359	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000171	0.00056	CbGpPWpGaD
Acitretin—Dry mouth—Doxorubicin—uterine cancer	0.00017	0.000355	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000168	0.000551	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SOCS3—uterine cancer	0.000168	0.00055	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—uterine cancer	0.000167	0.000348	CcSEcCtD
Acitretin—RARG—Gene Expression—CDKN2B—uterine cancer	0.000167	0.000547	CbGpPWpGaD
Acitretin—Infection—Doxorubicin—uterine cancer	0.000166	0.000346	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000165	0.000343	CcSEcCtD
Acitretin—Insomnia—Epirubicin—uterine cancer	0.000163	0.00034	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—uterine cancer	0.000162	0.000338	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—uterine cancer	0.000162	0.000338	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000162	0.000336	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000161	0.000528	CbGpPWpGaD
Acitretin—Somnolence—Epirubicin—uterine cancer	0.000161	0.000334	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CDKN2B—uterine cancer	0.00016	0.000526	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—uterine cancer	0.000159	0.000332	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—uterine cancer	0.000159	0.000331	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000158	0.000519	CbGpPWpGaD
Acitretin—Decreased appetite—Epirubicin—uterine cancer	0.000157	0.000327	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000156	0.000325	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—IGF1R—uterine cancer	0.000156	0.000511	CbGpPWpGaD
Acitretin—Fatigue—Epirubicin—uterine cancer	0.000156	0.000324	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000155	0.000509	CbGpPWpGaD
Acitretin—Pain—Epirubicin—uterine cancer	0.000154	0.000322	CcSEcCtD
Acitretin—Constipation—Epirubicin—uterine cancer	0.000154	0.000322	CcSEcCtD
Acitretin—RXRG—Gene Expression—CDKN2B—uterine cancer	0.000152	0.0005	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000152	0.000317	CcSEcCtD
Acitretin—RARG—Gene Expression—SMAD3—uterine cancer	0.000152	0.000499	CbGpPWpGaD
Acitretin—Insomnia—Doxorubicin—uterine cancer	0.000151	0.000315	CcSEcCtD
Acitretin—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000151	0.000494	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000151	0.000494	CbGpPWpGaD
Acitretin—Paraesthesia—Doxorubicin—uterine cancer	0.00015	0.000313	CcSEcCtD
Acitretin—RARB—Gene Expression—CDKN2B—uterine cancer	0.000149	0.00049	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000149	0.00049	CbGpPWpGaD
Acitretin—Feeling abnormal—Epirubicin—uterine cancer	0.000149	0.00031	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—uterine cancer	0.000149	0.000309	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000148	0.000308	CcSEcCtD
Acitretin—RXRA—Metabolism—STAR—uterine cancer	0.000147	0.000483	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKR1B1—uterine cancer	0.000147	0.000483	CbGpPWpGaD
Acitretin—Dyspepsia—Doxorubicin—uterine cancer	0.000147	0.000306	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—SMAD3—uterine cancer	0.000146	0.00048	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000146	0.000478	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000146	0.000478	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000145	0.000477	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—uterine cancer	0.000145	0.000303	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000144	0.0003	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—uterine cancer	0.000144	0.0003	CcSEcCtD
Acitretin—Urticaria—Epirubicin—uterine cancer	0.000143	0.000299	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000143	0.00047	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CDKN2B—uterine cancer	0.000143	0.00047	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CDKN2B—uterine cancer	0.000143	0.00047	CbGpPWpGaD
Acitretin—Constipation—Doxorubicin—uterine cancer	0.000143	0.000298	CcSEcCtD
Acitretin—Pain—Doxorubicin—uterine cancer	0.000143	0.000298	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—uterine cancer	0.000143	0.000297	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—uterine cancer	0.000143	0.000297	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000142	0.000465	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGFR2—uterine cancer	0.00014	0.000458	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SMAD3—uterine cancer	0.000139	0.000456	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000139	0.000456	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—uterine cancer	0.000138	0.000287	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000137	0.000285	CcSEcCtD
Acitretin—RARB—Gene Expression—SMAD3—uterine cancer	0.000136	0.000448	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SMAD3—uterine cancer	0.000133	0.000437	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—uterine cancer	0.000133	0.000277	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—uterine cancer	0.000133	0.000276	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—uterine cancer	0.000132	0.000275	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—uterine cancer	0.000132	0.000275	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000131	0.000431	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—MTHFR—uterine cancer	0.000131	0.00043	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMAD3—uterine cancer	0.000131	0.000429	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SMAD3—uterine cancer	0.000131	0.000429	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—uterine cancer	0.00013	0.00027	CcSEcCtD
Acitretin—Pruritus—Epirubicin—uterine cancer	0.000128	0.000266	CcSEcCtD
Acitretin—RBP1—Disease—ERBB2—uterine cancer	0.000125	0.000411	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ESR1—uterine cancer	0.000124	0.000407	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000124	0.000406	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—uterine cancer	0.000124	0.000257	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—uterine cancer	0.000123	0.000256	CcSEcCtD
Acitretin—ALB—Platelet degranulation—VEGFA—uterine cancer	0.00012	0.000395	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—uterine cancer	0.00012	0.00025	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—ESR1—uterine cancer	0.000119	0.000392	CbGpPWpGaD
Acitretin—Dizziness—Epirubicin—uterine cancer	0.000119	0.000249	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—uterine cancer	0.000118	0.000246	CcSEcCtD
Acitretin—RBP1—Disease—CDKN1B—uterine cancer	0.000116	0.000381	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR1—uterine cancer	0.000116	0.000379	CbGpPWpGaD
Acitretin—RXRA—Metabolism—POLD1—uterine cancer	0.000115	0.000379	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—uterine cancer	0.000115	0.000239	CcSEcCtD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000115	0.000376	CbGpPWpGaD
Acitretin—Diarrhoea—Doxorubicin—uterine cancer	0.000114	0.000238	CcSEcCtD
Acitretin—Rash—Epirubicin—uterine cancer	0.000114	0.000237	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—uterine cancer	0.000114	0.000237	CcSEcCtD
Acitretin—RXRG—Gene Expression—ESR1—uterine cancer	0.000114	0.000373	CbGpPWpGaD
Acitretin—Headache—Epirubicin—uterine cancer	0.000113	0.000236	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000112	0.000367	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR1—uterine cancer	0.000111	0.000365	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000111	0.000363	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—uterine cancer	0.00011	0.00023	CcSEcCtD
Acitretin—RBP1—Disease—CTNNB1—uterine cancer	0.00011	0.00036	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—uterine cancer	0.000109	0.000358	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKR1C1—uterine cancer	0.000108	0.000354	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—uterine cancer	0.000107	0.000223	CcSEcCtD
Acitretin—RBP1—Disease—PTEN—uterine cancer	0.000107	0.00035	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR1—uterine cancer	0.000107	0.00035	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ESR1—uterine cancer	0.000107	0.00035	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—uterine cancer	0.000106	0.000221	CcSEcCtD
Acitretin—ALB—Folate Metabolism—TP53—uterine cancer	0.000106	0.000348	CbGpPWpGaD
Acitretin—Rash—Doxorubicin—uterine cancer	0.000105	0.000219	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—uterine cancer	0.000105	0.000219	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CCL2—uterine cancer	0.000105	0.000345	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—uterine cancer	0.000105	0.000218	CcSEcCtD
Acitretin—RXRA—Gene Expression—PGR—uterine cancer	0.000104	0.000342	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000103	0.000337	CbGpPWpGaD
Acitretin—RBP1—Disease—EP300—uterine cancer	0.000102	0.000334	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.94e-05	0.000326	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—uterine cancer	9.92e-05	0.000207	CcSEcCtD
Acitretin—RXRA—Gene Expression—EZH2—uterine cancer	9.9e-05	0.000325	CbGpPWpGaD
Acitretin—RXRA—Metabolism—RRM2—uterine cancer	9.62e-05	0.000316	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—uterine cancer	9.53e-05	0.000313	CbGpPWpGaD
Acitretin—RXRA—Metabolism—DCN—uterine cancer	9.34e-05	0.000307	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IRF1—uterine cancer	9.3e-05	0.000305	CbGpPWpGaD
Acitretin—ALB—Metabolism—SRD5A2—uterine cancer	9.28e-05	0.000305	CbGpPWpGaD
Acitretin—ALB—Metabolism—NDUFB11—uterine cancer	9.28e-05	0.000305	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR2—uterine cancer	9.17e-05	0.000301	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.02e-05	0.000296	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP11A1—uterine cancer	8.8e-05	0.000289	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—uterine cancer	8.77e-05	0.000288	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.51e-05	0.000279	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	8.39e-05	0.000275	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—uterine cancer	8.32e-05	0.000273	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKR1C3—uterine cancer	8.31e-05	0.000273	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—uterine cancer	8.2e-05	0.000269	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—uterine cancer	8.12e-05	0.000266	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—uterine cancer	7.98e-05	0.000262	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—uterine cancer	7.67e-05	0.000252	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—uterine cancer	7.53e-05	0.000247	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—uterine cancer	7.48e-05	0.000245	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—uterine cancer	7.47e-05	0.000245	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—uterine cancer	7.29e-05	0.000239	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—uterine cancer	7.13e-05	0.000234	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—uterine cancer	6.98e-05	0.000229	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—uterine cancer	6.97e-05	0.000229	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—uterine cancer	6.95e-05	0.000228	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMAD3—uterine cancer	6.82e-05	0.000224	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—uterine cancer	6.75e-05	0.000222	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKR1B1—uterine cancer	6.71e-05	0.00022	CbGpPWpGaD
Acitretin—ALB—Metabolism—STAR—uterine cancer	6.71e-05	0.00022	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—uterine cancer	6.67e-05	0.000219	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.63e-05	0.000218	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—uterine cancer	6.49e-05	0.000213	CbGpPWpGaD
Acitretin—RXRA—Metabolism—STK11—uterine cancer	6.48e-05	0.000213	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP19A1—uterine cancer	6.48e-05	0.000213	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—uterine cancer	6.15e-05	0.000202	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—uterine cancer	6.15e-05	0.000202	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.08e-05	0.000199	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—uterine cancer	6.07e-05	0.000199	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.8e-05	0.00019	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—uterine cancer	5.74e-05	0.000188	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—uterine cancer	5.56e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	5.34e-05	0.000175	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—uterine cancer	5.28e-05	0.000173	CbGpPWpGaD
Acitretin—ALB—Metabolism—POLD1—uterine cancer	5.27e-05	0.000173	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—uterine cancer	5.23e-05	0.000172	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—uterine cancer	5.14e-05	0.000169	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—uterine cancer	5.1e-05	0.000167	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKR1C1—uterine cancer	4.93e-05	0.000162	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—uterine cancer	4.88e-05	0.00016	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—uterine cancer	4.87e-05	0.00016	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—uterine cancer	4.48e-05	0.000147	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—uterine cancer	4.44e-05	0.000146	CbGpPWpGaD
Acitretin—ALB—Metabolism—RRM2—uterine cancer	4.39e-05	0.000144	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—uterine cancer	4.31e-05	0.000141	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.29e-05	0.000141	CbGpPWpGaD
Acitretin—ALB—Metabolism—DCN—uterine cancer	4.26e-05	0.00014	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—uterine cancer	4.2e-05	0.000138	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	4.17e-05	0.000137	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—uterine cancer	4.1e-05	0.000134	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—uterine cancer	4.02e-05	0.000132	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP11A1—uterine cancer	4.02e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—uterine cancer	3.92e-05	0.000129	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—uterine cancer	3.85e-05	0.000126	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—uterine cancer	3.85e-05	0.000126	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKR1C3—uterine cancer	3.79e-05	0.000124	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	3.41e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Metabolism—STK11—uterine cancer	2.95e-05	9.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP19A1—uterine cancer	2.95e-05	9.69e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—uterine cancer	2.9e-05	9.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.77e-05	9.1e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—uterine cancer	2.75e-05	9.03e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—uterine cancer	2.72e-05	8.92e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—uterine cancer	2.71e-05	8.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.64e-05	8.68e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—uterine cancer	2.58e-05	8.47e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—uterine cancer	2.34e-05	7.67e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—uterine cancer	2.22e-05	7.28e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—uterine cancer	2.15e-05	7.05e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—uterine cancer	2.08e-05	6.82e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—uterine cancer	2.01e-05	6.58e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—uterine cancer	1.99e-05	6.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.96e-05	6.42e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—uterine cancer	1.91e-05	6.27e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—uterine cancer	1.76e-05	5.76e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—uterine cancer	1.56e-05	5.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—uterine cancer	1.23e-05	4.05e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—uterine cancer	1.18e-05	3.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—uterine cancer	8.71e-06	2.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—uterine cancer	7.12e-06	2.34e-05	CbGpPWpGaD
